Business · 07/05/2021
FDA Establishes Public Docket for Pharmacy Compounding Advisory Committee Meeting
The FDA is requesting public comments on the establishment of a public docket for a forthcoming meeting of the Pharmacy Compounding Advisory Committee, which advises on drug compounding and related issues under the FD&C Act.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →